Neoleukin Therapeutics (NLTX) Stock Chart & Stock Price History $21.26 +0.98 (+4.83%) As of 07/9/2025 Add Compare Share Share Chart Stock AnalysisChartCompetitorsInsider TradesSEC FilingsTrendsBuy This Stock Neoleukin Therapeutics Stock Price Performance The Neoleukin Therapeutics (NLTX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 44.87%, with a year-to-date return of -7.44%. In the past month, the stock has increased 6.78%, reflecting recent market activity. As of the latest close, Neoleukin Therapeutics traded at $20.28 with a market cap of $190.59 million and volume of 97,331 shares. Five years ago, the stock traded at a split-adjusted price of $258.60, representing a 91.78% decrease over that period. At the time, it had a market cap of $491.39 million and a volume of 16,400 shares. Receive NLTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Neoleukin Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+7.65%1 Month Performance+6.78%3 Month Performance+135.44%Year-To-Date Performance-7.44%1 Year Performance-44.87%5 Year Performance-91.78% NLTX Stock Chart for Thursday, July, 10, 2025 NLTX Chart by TradingView Neoleukin Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/09/2025$19.50$20.28+4.00%$20.80$19.6297,331 shs$190.59 million07/08/2025$20.09$19.50-2.94%$20.55$19.37221,816 shs$183.26 million07/07/2025$20.09$20.09$20.71$19.0175,550 shs$188.81 million07/04/2025$19.75$20.09+1.72%$20.71$19.0175,550 shs$188.81 million07/03/2025$19.19$19.75+2.92%$21.19$19.08240,714 shs$185.61 million07/02/2025$14.95$19.19+28.36%$21.19$14.651.35 million shs$180.35 million07/01/2025$16.16$14.95-7.49%$16.33$14.93205,629 shs$140.50 million06/30/2025$16.16$16.16$16.86$15.90436,968 shs$151.87 million06/27/2025$17.20$16.57-3.66%$17.26$16.30117,117 shs$155.73 million06/26/2025$17.20$17.20$18.21$16.55238,965 shs$161.65 million Get the Latest News and Ratings for NLTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Neoleukin Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/25/2025$17.22$17.20-0.12%$18.21$16.55238,965 shs$161.65 million06/24/2025$17.76$17.22-3.04%$18.05$16.8692,384 shs$161.83 million06/23/2025$17.76$17.76$18.56$17.70108,535 shs$166.91 million06/20/2025$18.30$18.30$19.57$18.22203,614 shs$171.98 million06/19/2025$18.42$18.30-0.65%$19.57$18.22203,614 shs$171.98 million06/18/2025$18.97$18.42-2.90%$21.43$18.29152,182 shs$173.11 million06/17/2025$19.76$18.97-4.00%$20.66$18.75158,209 shs$178.28 million06/16/2025$19.76$19.76$20.62$19.51112,718 shs$185.70 million06/13/2025$20.92$20.40-2.49%$21.75$20.13151,561 shs$191.72 million06/12/2025$21.58$20.92-3.06%$22.00$20.68133,476 shs$196.61 million06/11/2025$19.91$21.58+8.39%$21.73$19.25128,823 shs$202.81 million06/10/2025$21.83$19.91-8.80%$21.89$19.13245,841 shs$187.11 million06/09/2025$21.83$21.83$25.19$21.50224,694 shs$205.16 million Related Companies Evolus Stock Price Chart Arbutus Biopharma Stock Price Chart Autolus Therapeutics Stock Price Chart Relay Therapeutics Stock Price Chart Upstream Bio Stock Price Chart Iovance Biotherapeutics Stock Price Chart Dianthus Therapeutics Stock Price Chart atai Life Sciences Stock Price Chart Sage Therapeutics Stock Price Chart Amylyx Pharmaceuticals Stock Price Chart Receive NLTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Neoleukin Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NLTX) was last updated on 7/10/2025 by MarketBeat.com Staff From Our PartnersI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredHow a Kansas farm boy gained 1,285% in two daysA former farm kid placed a simple trade… and cashed out a 1,285% gain two days later. It wasn’t crypto or a...TradeSmith | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neoleukin Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neoleukin Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NLTX Stock Alerts